Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion Syndrome (RECOVERY)
Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion Syndrome - A Prospective, Comparative, Randomized, Simple-blinded, Monocentric Investigation [RGncon Investigation]
Sponsor: RCTs
Listed as NCT05647304, this NA trial focuses on Acute Concussion Syndrome and remains completed. Sponsored by RCTs, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Apr 2025 — Present [monthly]
Completed NA
-
Jan 2025 — Apr 2025 [monthly]
Completed NA
-
Sep 2024 — Jan 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Aug 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 1 earlier version
-
Jan 2023 — Aug 2023 [monthly]
Recruiting NA
First recorded
Oct 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- RCTs
- REGEnLIFE SAS
- University Hospital, Montpellier
For direct contact, visit the study record on ClinicalTrials.gov .